191 related articles for article (PubMed ID: 18626804)
1. Radiopharmaceuticals: molecular imaging using positron emission tomography.
Antoni G; Långström B
Handb Exp Pharmacol; 2008; (185 Pt 1):177-201. PubMed ID: 18626804
[TBL] [Abstract][Full Text] [Related]
2. Developing new molecular imaging probes for PET.
Serdons K; Verbruggen A; Bormans GM
Methods; 2009 Jun; 48(2):104-11. PubMed ID: 19318126
[TBL] [Abstract][Full Text] [Related]
3. Target-specific delivery of peptide-based probes for PET imaging.
Chen K; Conti PS
Adv Drug Deliv Rev; 2010 Aug; 62(11):1005-22. PubMed ID: 20851156
[TBL] [Abstract][Full Text] [Related]
4. Radiopharmaceutical chemistry for positron emission tomography.
Li Z; Conti PS
Adv Drug Deliv Rev; 2010 Aug; 62(11):1031-51. PubMed ID: 20854860
[TBL] [Abstract][Full Text] [Related]
5. Molecular tracers for the PET and SPECT imaging of disease.
Pimlott SL; Sutherland A
Chem Soc Rev; 2011 Jan; 40(1):149-62. PubMed ID: 20818455
[TBL] [Abstract][Full Text] [Related]
6. [Positron emission tomography: a clinical and biological research tool].
Kotzki PO
J Soc Biol; 2004; 198(2):163-8. PubMed ID: 15368968
[TBL] [Abstract][Full Text] [Related]
7. The use of imaging in preclinical drug development.
Vanderheyden JL
Q J Nucl Med Mol Imaging; 2009 Aug; 53(4):374-81. PubMed ID: 19834446
[TBL] [Abstract][Full Text] [Related]
8. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative.
Ross TL; Honer M; Lam PY; Mindt TL; Groehn V; Schibli R; Schubiger PA; Ametamey SM
Bioconjug Chem; 2008 Dec; 19(12):2462-70. PubMed ID: 19053298
[TBL] [Abstract][Full Text] [Related]
9. Principles and clinical applications of positron emission tomography.
Gardner SF; Green JA; Bednarczyk EM; Farnett L; Miraldi F
Am J Hosp Pharm; 1992 Jun; 49(6):1499-506. PubMed ID: 1530002
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of 11C, 18F, 15O, and 13N radiolabels for positron emission tomography.
Miller PW; Long NJ; Vilar R; Gee AD
Angew Chem Int Ed Engl; 2008; 47(47):8998-9033. PubMed ID: 18988199
[TBL] [Abstract][Full Text] [Related]
11. [Strategy for development of imaging biomarkers].
Ishiwata K
Nihon Shinkei Seishin Yakurigaku Zasshi; 2009 Apr; 29(2):67-71. PubMed ID: 19562944
[TBL] [Abstract][Full Text] [Related]
12. PET & SPECT instrumentation.
Spanoudaki VC; Ziegler SI
Handb Exp Pharmacol; 2008; (185 Pt 1):53-74. PubMed ID: 18626798
[TBL] [Abstract][Full Text] [Related]
13. Positron emission tomography for use in microdosing studies.
Wagner CC; Müller M; Lappin G; Langer O
Curr Opin Drug Discov Devel; 2008 Jan; 11(1):104-10. PubMed ID: 18175273
[TBL] [Abstract][Full Text] [Related]
14. Adenosine receptor ligands and PET imaging of the CNS.
Bauer A; Ishiwata K
Handb Exp Pharmacol; 2009; (193):617-42. PubMed ID: 19639295
[TBL] [Abstract][Full Text] [Related]
15. Quantitative small animal PET.
Shoghi KI
Q J Nucl Med Mol Imaging; 2009 Aug; 53(4):365-73. PubMed ID: 19834445
[TBL] [Abstract][Full Text] [Related]
16. Positron emission tomography/computed tomography: the current technology and applications.
Mittra E; Quon A
Radiol Clin North Am; 2009 Jan; 47(1):147-60. PubMed ID: 19195540
[TBL] [Abstract][Full Text] [Related]
17. Molecular-genetic imaging based on reporter gene expression.
Kang JH; Chung JK
J Nucl Med; 2008 Jun; 49 Suppl 2():164S-79S. PubMed ID: 18523072
[TBL] [Abstract][Full Text] [Related]
18. Small-animal PET: a promising, non-invasive tool in pre-clinical research.
Schnöckel U; Hermann S; Stegger L; Law M; Kuhlmann M; Schober O; Schäfers K; Schäfers M
Eur J Pharm Biopharm; 2010 Jan; 74(1):50-4. PubMed ID: 19482080
[TBL] [Abstract][Full Text] [Related]
19. [Application of pre-clinical PET imaging for drug development].
Tsukada H
Nihon Shinkei Seishin Yakurigaku Zasshi; 2011 Nov; 31(5-6):231-7. PubMed ID: 22256612
[TBL] [Abstract][Full Text] [Related]
20. Radiopharmaceutical pharmacokinetics in animals: critical considerations.
Giron MC
Q J Nucl Med Mol Imaging; 2009 Aug; 53(4):359-64. PubMed ID: 19834444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]